Zobrazeno 1 - 10
of 87
pro vyhledávání: '"Olga Martínez"'
Autor:
Aleix Prat, Olga Martínez-Sáez
Publikováno v:
JCO Oncology Practice. 17:594-604
Human epidermal growth factor receptor 2 (HER2) is overexpressed and/or amplified in approximately 20% of breast cancers, conferring an aggressive tumor behavior but also an opportunity for targeted therapies. In the advanced setting, the prognosis o
Autor:
Reyes Gámez-Belmonte, Belén Rivero-Gutiérrez, Fermín Sánchez de Medina, Olga Martínez-Augustin, María Arredondo-Amador
Publikováno v:
American Journal of Physiology-Gastrointestinal and Liver Physiology. 321:G157-G170
The study was funded the following grants of the Ministerio de Economía y Competitividad and the Fondo Europeo de Desarrollo Regional FEDER (SAF2011-22922, SAF2011-22812, BFU2014- 57736-P, and AGL2014-58883-R) and Junta de Andalucía (CTS164, CTS235
Autor:
Anwesha Chaudhury, Nuria Chic, Tetiana Taran, D. Martinez, Nadia Solovieff, Karen Rodriguez-Lorenc, Fara Brasó-Maristany, Aleix Prat, Faye Su, Laia Paré, Olga Martínez, Naveen Babbar
Publikováno v:
Cancer Research. 81:GS1-04
Background: The prognostic and predictive value of the 4 main intrinsic subtypes of breast cancer (ie, luminal A [LumA], luminal B [LumB], human epidermal growth factor receptor 2 enriched [HER2E], and basal-like) in hormone receptor-positive, HER2
Autor:
Fermín Sánchez de Medina, Olga Martínez-Augustin, María Arredondo-Amador, Raquel González, Carlos J. Aranda
Publikováno v:
American journal of physiology. Gastrointestinal and liver physiology. 321(6)
The glucocorticoid receptor NR3C1 is expressed in multiple cell types in the gut and elsewhere. Intestinal epithelial cells both produce and respond to glucocorticoids in different physiological and pathological contexts. In experimental colitis gluc
Autor:
Tetiana Taran, Nadia Solovieff, Olga Martínez-Sáez, D. Martinez, Naveen Babbar, Agnes Lteif, Fara Brasó-Maristany, Anwesha Chaudhury, Nuria Chic, Aleix Prat, Laia Paré, Fei Su
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 39(13)
PURPOSE The prognostic and predictive value of intrinsic subtypes in hormone receptor–positive, human epidermal growth factor receptor 2–negative advanced breast cancer treated with endocrine therapy and ribociclib (RIB) is currently unknown. We
Autor:
Iker Uriarte, R. Rosales, Marta R. Romero, Fermín Sánchez de Medina, Jose J.G. Marin, Ana Peleteiro-Vigil, Maria J. Monte, Olga Martínez-Augustin, Carlos J. Aranda, Oscar Briz, Borja Ocón, Matías A. Avila, Faten A. Al-Aqil, Raquel González
Publikováno v:
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1864:2927-2937
At high doses, glucocorticoids (GC) have been associated with enhanced serum bile acids and liver injury. We have evaluated the effect of GC, in the absence of hepatotoxicity, on FXR/FGF91(Fgf15)/FGF21-mediated ileum-liver crosstalk. Rats and mice (w
Autor:
María Arredondo-Amador, Raquel González, Carlos J. Aranda, Fermín Sánchez de Medina, Olga Martínez-Augustin, Borja Ocón
Publikováno v:
British journal of pharmacologyREFERENCES. 178(12)
Background and purpose Glucocorticoids are the first line treatment for the flare-ups of inflammatory bowel disease, but they have significant limitations. The objective of this study is to investigate whether glucocorticoid epithelial actions contri
Autor:
Tomás Pascual, Mafalda Oliveira, Eva Ciruelos, Meritxell Bellet Ezquerra, Cristina Saura, Joaquin Gavilá, Sonia Pernas, Montserrat Muñoz, Maria J. Vidal, Mireia Margelí Vila, Juan M. Cejalvo, Blanca González-Farré, Martin Espinosa-Bravo, Josefina Cruz, Francisco Javier Salvador-Bofill, Juan Antonio Guerra, Ana María Luna Barrera, Miriam Arumi de Dios, Stephen Esker, Pang-Dian Fan, Olga Martínez-Sáez, Guillermo Villacampa, Laia Paré, Juan M. Ferrero-Cafiero, Patricia Villagrasa, Aleix Prat
Publikováno v:
Dipòsit Digital de la UB
Universidad de Barcelona
Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid
Frontiers in Oncology
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
Frontiers in Oncology, Vol 11 (2021)
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
Scientia
Universidad de Barcelona
Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid
Frontiers in Oncology
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
Frontiers in Oncology, Vol 11 (2021)
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
Scientia
Càncer de mama; Puntuació CelTIL; Patritumab deruxtecan Cáncer de mama; Puntuación CelTIL; Patritumab deruxtecan Breast Cancer; CelTIL Score; Patritumab deruxtecan Background: Preclinical data support a key role for the human epidermal growth fac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1daac2f036bf4a3078a12492554c1412
http://hdl.handle.net/2445/177728
http://hdl.handle.net/2445/177728
Autor:
Miguel Martín, Laia Paré, Barbara Adamo, Roberta Fasani, Blanca Gonzalez-Farre, Benedetta Conte, Giovanna Sabarese, Carlos H. Barrios, Fara Brasó-Maristany, Esther Sanfeliu, Mariavittoria Locci, Giuseppe Perrone, Francesca Zalfa, Esther Barnadas, Olga Martínez-Sáez, Aranzazu Fernandez-Martinez, Ana Lluch, Maria Vidal, Joaquín Gavilá, Tomás Pascual, Aleix Prat, Francesco Schettini, Sabino De Placido, Patricia Villagrasa, Vicente Peg, Nuria Chic, Juan Miguel Cejalvo
Publikováno v:
Dipòsit Digital de la UB
Universidad de Barcelona
Scientia
NPJ Breast Cancer
npj Breast Cancer, Vol 7, Iss 1, Pp 1-13 (2021)
Universidad de Barcelona
Scientia
NPJ Breast Cancer
npj Breast Cancer, Vol 7, Iss 1, Pp 1-13 (2021)
Càncer de mama; Genòmica del càncer; Recerca translacional Cáncer de mama; Genómica del cáncer; Investigación traslacional Breast cancer; Cancer genomics; Translational research Novel antibody-drug conjugates against HER2 are showing high acti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5c10b99479fa39b069aa421ecf890520
http://hdl.handle.net/2445/175264
http://hdl.handle.net/2445/175264
Autor:
Irene Carrión-Barberà, Ivan Castellví, Carmen Carrasco Cubero, Javier Narváez, Pilar Trenor Larra, Susana Holgado, Iñigo Rúa-Figueroa, Marina Rodríguez López, Ana Pérez Gómez, Mónica Ibáñez, Beatriz Joven, Patricia Alcocer, Tatiana Cobo-Ibáñez, Alejandro Gómez Gómez, Eva Tomero, Ernesto Trallero-Araguás, Carlos Sánchez-Piedra, Mercedes Freire, Rafaela Ortega-Castro, Alberto Ruiz-Román, Nuria Lozano, Laura Nuño-Nuño, Carmen Larena, Francisca Sivera, Fredeswinda Romero-Bueno, J. Belzunegui, Carmen Barbadillo, Olga Martínez-González, Esmeralda Delgado-Frías, María Esther Ruiz-Lucea, Vega Jovani, Julia Martínez-Barrio, Jordi Camins, José M. Pego-Reigosa
Publikováno v:
Reumatologia clinica.
Objectives To describe the methods of the Spanish Registry of patients with idiopathic inflammatory myopathy (IIM) (Myo-Spain), as well as its strengths and limitations. The main objective of the project is to analyse the evolution and clinical manag